Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
2573 Views
Dr M Sreelatha, Kerala 12 January 2018
Emerging evidence suggest that dysfunctional mitochondria have a primary role in the development of CKD as well as in comorbidities related to CKD and underline their role as new therapeutic targets. Our understanding is still quite immature.
Mitochondria-directed therapies have the potential for prevention and management of renal diseases.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}